Margaret Faul oversees drug substance technologies and has spent more than two decades at Amgen. She moved to Cambridge just ...
The release this spring of the Boston Business Journal’s Employer Inclusivity Index underscores a vital truth for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results